About the Platform
Smaller companies are some of Europe's greatest innovators. From food to therapies, smaller biotechnology companies are paving the way for a healthy and sustainable continent, addressing some of society's most pressing and complex challenges.
EuropaBio's Small and Medium-sized companies (SME) Platform connects smaller companies acting across all biotechnology sectors to share experiences, identify challenges and propose policy recommendations.
Throughout the year, the Platform holds informal discussions between SME leaders on EU topics that impact their ability to compete, launch products and provide services in Europe. The SME Platform creates supporting material to tell their stories, including reports, case studies and video and audio records.
Through EuropaBio, SME executives engage with European and national policymakers and relevant stakeholders to advocate for SME priorities and promote an innovative and competitive environment that allows smaller companies to thrive in Europe.
The SME Platform reflects the diversity of the European entrepreneurial ecosystem and its complex challenges.
- Reducing regulatory burden
- Improving market access
- Ensuring intellectual property protection and a competitive and innovative landscape
- Improving access to financing and investment
- Promote the development of skilled professionals and biomanufacturing
The SME Platform has priorities developed with Members for work with Member and external SMEs throughout the year. Priorities in 2021 include:
Policy developments of significance to Healthcare and Industrial Biotechnology SMEsFinancial development pathways for SMEs
SME representation in the 25th EuropaBio Anniversary programme
Presentation of the Start Up City at the European Forum for Industrial Biotechnology